Navigation Links
Sanofi-Aventis Allows Thais To Make Plavix

The generic version of Plavix, the heart disease medicine of Sanofi-Aventis will be made indigenously in Thailand. This was announced by the pharma company on Tuesday.//

As per the offer made by Sanofa-Aventis, the health ministry has approved plans to buy or make imitated version of the drug. The statement released by the drug firm states that indigenous making of the heart drug will benefit the poorer Thai patients. According to a health official the company had offered a special quota of 3.4 million Plavix tablets for 34,000 patients.

The drug industry was shocked last November by the action of Thailand government when it decided to supersede the patent on Efavirenz, a drug for HIV from Merck & Co. Later licenses were issued for Plavix and Kaletra, an AIDS drug from the US pharma giant Abbott Laboratories. But Abbott reacted sharply to this by refusing to launch new drugs in Thailand which was not welcomed by AIDS activists all over the world.

Drug companies do not approve such moves as they are investing a lot of money in research and development and in the formulation of a new drug. Fabrice Baschiera, general manager of Sanofi-Aventis in Thailand said, "The best way to find solutions to difficult health care challenges is to reject confrontation and engage in constructive dialogue with a view to increasing private and public sector partnership."

On the other hand, World Trade Organization permits governments to issue compulsory licenses and allows others to make a patented medicine without the approval of a foreign patent owner. But according to Thailand government essential medicines are too expensive for the country’s health care program.
JYT
'"/>




Page: 1

Related medicine news :

1. FDA Gives Green Signal To Sanofi-Aventis SAs Cancer Drug Taxotere
2. Sanofi-Aventis sets the ball rolling for trials of H7N1 bird flu vaccine
3. U S Government Allows Non-prescription Diet Pill
4. British Court Allows Argument in Favour of Open-air Funerals
5. Plavix Gets FDA Okay for New Indication
6. Plavix Safe During and After Heart Bypass
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Sanofi Aventis Allows Thais Make Plavix

(Date:5/16/2008)... Contract Covers More than 500 Workers, WASHIN...500 paramedics,and emergency medical technicians i...ington area have ratified their first-ever contrac...these workers are now covered by a,strong contract...ement,future," said Teamsters General President Ji...
(Date:5/16/2008)...Study finds chronic disease sufferers gain benefit...Y, May 16 (HealthDay News) -- Taking activated vit...oderate to severe chronic kidney disease by about ...two-year study of more than 1,400 patients, those ...ivated vitamin D, had their overall risk of death ...
(Date:5/16/2008)... PALM BEACH, Fla., May 16 /PRNewswire-USNewswir...d more often by Americans, particularly our,childr... individuals, have,significant hearing loss and th... out of every 100 school age children have some fo...ion to this social and economic problem,is what le...
(Date:5/16/2008)... Live Web Cast Scheduled for May 19 at 10:15...-FirstCall/ - Response Biomedical,Corporation (TSX... Kay,Chief Executive Officer, is scheduled to pre...lthcare Conference on Monday May 19th at 10:15 a.m...be available on the Company,s,Web site at, http://...
Breaking Medicine News(10 mins):Health News:Vitamin D Use Linked to Lower Mortality in Kidney Patients 2Health News:Huh, What Did You Say?: May is 'Better Hearing and Speech Month' 2Health News:Huh, What Did You Say?: May is 'Better Hearing and Speech Month' 3Health News:Response Biomedical Corporation to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference 2
...that short sessions (a few minutes a day) of very ...oderate exercises done for hours//. Martin Gibala...r University and his team conducted this study on ...aditional endurance training that was published in...
...ns who live in far-flung areas run a grave risk of...rs, primarily due to an increase in the rates of//... stated by a report released by The Canadian Insti...ding to the report the annual death rate per 100,0...
...h in Wales said that pregnant women may be risking...ing alcohol during pregnancy. Baby charity Tommy's...omen admitted that they drank more than permitted....units once or twice a week. "There is no proven sa...
... that Private clinics who share the status with NH...ent figures indicate. This responsibility was give...klog of waiting lists and to enable better choice ...the permission to effect minor surgery, ENT treatm...
Other Medicine News:Health News:Rural Canadians, Take Care Of Your Health 2
(Date:5/16/2008)...J., May 16 /- Veridex, LLC announced ...Corporation of America Holdings,(LabCorp), has com...,prostate cancer. The new assay uses the biologica...cer, detecting the methylation of the gene,GST-Pi....primarily in,cancer. Veridex is developing the met...
(Date:5/15/2008)...zerland, May 15 /- Patients with brea...ommon cancers, can expect,further treatment advanc...(trastuzumab) following new data that is being pre...cology (ASCO) annual meeting in Chicago at,the end... the meeting which,is the premier event for cancer...
(Date:5/15/2008)...Australia, May 15 /- Cytopi...ract for its upcoming oral,presentation on CYT997 ...,of Clinical Oncology (ASCO) will be accessible to...rg ) from 9pm on Thursday 15 May (US EDT)., The o...CYT997, a novel,cytotoxic and vascular disrupting ...
(Date:5/15/2008)...sults obtained with a newly cleared device to iden...interest that are associated with ... Mass., May 15 /- InfraReDx, Inc. tod...in Royal Oak, Mich., have,successfully used its Li...dergoing a cardiac catheterization. This is the fi...
Breaking Medicine Technology:New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 2New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 3New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 4New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 5New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 6First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 2First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 3First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 4Family history of alcoholism affects response to drug used to treat heavy drinking 1563 1Family history of alcoholism affects response to drug used to treat heavy drinking 1563 2New study shows fish respond quickly to changes in mercury deposition 452 1New study shows fish respond quickly to changes in mercury deposition 452 2New study shows fish respond quickly to changes in mercury deposition 452 3 3Ci 3ECosby 3C i 3E Star Tackles a Silent Heart Threat 1557 1 3Ci 3ECosby 3C i 3E Star Tackles a Silent Heart Threat 1557 2 3Ci 3ECosby 3C i 3E Star Tackles a Silent Heart Threat 1557 3 3Ci 3ECosby 3C i 3E Star Tackles a Silent Heart Threat 1557 4IsoTis Integra Merger 678 1IsoTis Integra Merger 678 2IsoTis Integra Merger 678 3IsoTis Integra Merger 678 4IsoTis Integra Merger 678 5
... MISSISSAUGA, ON, July 09, 2007 /PRNewswire-FirstC...hat identifies, develops,and commercializes differ...nounced that a study presented by investigators fr...niversity at the 11th,meeting of The Japanese Asso...d on July 5-6, 2007 demonstrated the increased,rad...
... WORCESTER, Massachusetts, July 08, 2007 /PRNewswi...eed to Urgently,Implement Hospital-Wide Strategies... Patient Risk for VTE and Provide Appropriate,prop...TE) risk is high among hospital,patients and most ...dequate prophylaxis according to data from the int...
Other Medicine Technology:YM BioSciences Announces Preclinical Data Confirming Nimotuzumab,Binds to the EGF Receptor and Potentiates Radiotherapy 2YM BioSciences Announces Preclinical Data Confirming Nimotuzumab,Binds to the EGF Receptor and Potentiates Radiotherapy 3YM BioSciences Announces Preclinical Data Confirming Nimotuzumab,Binds to the EGF Receptor and Potentiates Radiotherapy 4International ENDORSE Study Shows That the Majority of Hospitalized,Patients Surveyed are at Risk for VTE and Many do not Receive,Recommended VTE prophylaxis 2International ENDORSE Study Shows That the Majority of Hospitalized,Patients Surveyed are at Risk for VTE and Many do not Receive,Recommended VTE prophylaxis 3International ENDORSE Study Shows That the Majority of Hospitalized,Patients Surveyed are at Risk for VTE and Many do not Receive,Recommended VTE prophylaxis 4
...3 mm is a resorbable repair device used in conjunc...ng device to attach soft tissue to bone using sutu... a prepared hole in the bone, and is used to attac... a resorbable copolymer, derived from glycolide an...
This type of anchor is generally used when anchor size may be an issue. This 2.9mm anchor is packaged sterile and comes pre-loaded with sutures (1-0 or 2-0) and needles. Although pre-drilling is not
...ile Anchor is a nonabsorbable repair device to att...is implanted into a prepared hole in the bone and ...rs are manufactured from Titanium (6AL4V ELI) allo...e coated with Titanium Nitride (TiN) which conform...
The MINI-TAG™ instrument systems are indicated for ulnar collateral ligament repair, scapholunate dissolution, flexor avulsions, and carpometa-carpal arthroplasty.
Medicine Products: